A Novel Role for Relaxin-2 in the Pathogenesis of Primary Varicosis
Open Access
- 21 June 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (6) , e39021
Abstract
Varicose veins affect up to 40% of men and up to 51% of women. The pathophysiology of primary varicosis is poorly understood. Theories ranging from incompetence of the venous valves to structural changes in the vein wall have been proposed. We analyzed the functional state of the intramural smooth muscle cells (n = 14 pairs matched for age and gender) and the expression of relaxin-2 and its receptors RXFP1 and RXFP2 in samples of varicose and healthy great saphenous veins (GSV) (n = 21 healthy GSV; n = 46 varicose GSV). Relaxin-2 and RXFP1 contents were determined in tissue samples (n = 9 samples per group). Pharmacological analyses were performed in a perfusion chamber. Morphometric determination of the nuclear size of the smooth muscle compartment yielded no significant difference in varicose GSV in comparison with the healthy controls. Relaxin-2 and its receptors were expressed in the muscular layer, endothelial cells and in blood vessels contained in the vein wall. Immunohistochemical expression of relaxin-2, RXFP1 and RXFP2 was significantly decreased in varicose GSV. Relaxin-2 and RXFP1 measured by ELISA and Western Blot were decreased in varicose GSV (relaxin-2 ELISA healthy vs. varicose GSV: 12.49±0.66 pg/mg versus 9.12±3.39 pg/mg of total protein; p = 0.01; Student's T-test). Contractions of vein samples induced by cholinergic or adrenergic stimulation were antagonized by relaxin-2. We report that relaxin-2 and its receptors RXFP1 and RXFP2 are expressed in GSV and that their expression is significantly decreased in varicose GSV. Further, we were able to demonstrate a functional pharmacological relaxin-2 system in varicose GSV. Our results suggest a novel role for relaxin-2 in the pathogenesis of primary varicosis, rendering relaxin-2 a novel possible pharmacological agent for the treatment of this widely prevailing venous disease.Keywords
This publication has 17 references indexed in Scilit:
- Experimental hypertension triggers varicosis‐like maladaptive venous remodeling through activator protein‐1The FASEB Journal, 2011
- Relaxin: Review of Biology and Potential Role in Treating Heart FailureCurrent Heart Failure Reports, 2010
- The hemodynamics and diagnosis of venous diseaseJournal of Vascular Surgery, 2007
- Primary chronic venous disordersJournal of Vascular Surgery, 2007
- The role of smooth muscle in the pathogenesis of pelvic organ prolapse—an immunohistochemical and morphometric analysis of the cervical third of the uterosacral ligamentInternational Urogynecology Journal, 2007
- Drugs of the future: the hormone relaxinCellular and Molecular Life Sciences, 2007
- The Histopathology of Varicose Vein DiseaseAngiology, 2006
- Smooth Muscle Cell Hypertrophy in Varicose Veins Is Associated with Expression of Estrogen Receptor-βJournal of Vascular Research, 2005
- Estrogen and progesterone receptors in normal and varicose saphenous veinsCardiovascular Surgery, 1999
- Assessment of wall structure and composition of varicose veins with reference to collagen, elastin and smooth muscle contentEuropean Journal of Vascular and Endovascular Surgery, 1996